Joanne Parks, MD
Psychiatry · Barrington, ILNPI 1619019148
Payments from drug & device makers
Across 575 payments — averaging $283.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$149K
- E.r. Squibb & Sons, L.L.C.$9K
- Lundbeck LLC$676
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$549
- Vanda Pharmaceuticals Inc.$483
- Otsuka America Pharmaceutical, Inc.$476
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 336 | $149,296 |
| E.r. Squibb & Sons, L.L.C. | 17 | $8,953 |
| Lundbeck LLC | 43 | $676 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $549 |
| Vanda Pharmaceuticals Inc. | 19 | $483 |
| Otsuka America Pharmaceutical, Inc. | 26 | $476 |
| Axsome Therapeutics, Inc. | 7 | $330 |
| Alkermes, Inc. | 12 | $276 |
| Neuronetics, Inc. | 8 | $268 |
| Teva Pharmaceuticals USA, Inc. | 11 | $241 |
| Neurocrine Biosciences, Inc. | 7 | $180 |
| Harmony Biosciences LLC | 5 | $159 |
| Supernus Pharmaceuticals, Inc. | 7 | $142 |
| Sunovion Pharmaceuticals Inc. | 7 | $107 |
| Avanir Pharmaceuticals, Inc. | 6 | $94 |
| Johnson & Johnson | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $76 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Ironshore Pharmaceuticals Inc. | 3 | $71 |
| Corium, LLC | 3 | $67 |
| Livanova USA, Inc. | 2 | $59 |
| Tris Pharma Inc | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| Shire North American Group Inc | 2 | $28 |
| Indivior Inc. | 2 | $26 |
| Neos Therapeutics, LP | 1 | $23 |
| Bausch Health US, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
| Orexo US, Inc. | 1 | $11 |
How this compares
$162,875 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Barrington
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.